HOME >> BIOLOGY >> NEWS
A genetic 'gang of 4' drives spread of breast cancer

Studies of human tumor cells implanted in mice have shown that the abnormal activation of four genes drives the spread of breast cancer to the lungs. The new studies by Howard Hughes Medical Institute researchers reveal that the aberrant genes work together to promote the growth of primary breast tumors. Cooperation among the four genes also enables cancerous cells to escape into the bloodstream and penetrate through blood vessels into lung tissues.

Although shutting off these genes individually can slow cancer growth and metastasis, the researchers found that turning off all four together had a far more dramatic effect on halting cancer growth and metastasis. Metastasis occurs when cells from a primary tumor break off and invade another organ. It is the deadliest transformation that a cancer can undergo, and therefore researchers have been looking for specific genes that propel metastasis.

In the newly published experiments, the researchers also found that they could reduce the growth and spread of human breast tumors in mice by simultaneously targeting two of the proteins produced by these genes, using drugs already on the market. The researchers are exploring clinical testing of combination therapy with the drugscetuximab (trade name Erbitux) and celecoxib (Celebrex)to treat breast cancer metastasis.

The research team, led by Howard Hughes Medical Institute investigator Joan Massagu at the Memorial Sloan-Kettering Cancer Center, published its findings in articles in the April 12, 2007, issue of the journal Nature and in the online early edition of the Proceedings of the National Academy of Sciences on April 9, 2007.

In an earlier study, Massagu and his colleagues had identified 18 genes whose abnormal activity is associated with breast cancers ability to spread to the lungs. In the new study published in Nature, Massagu and his colleagues at Sloan-Kettering, along with researchers from Hospital Clinic de Barcelona and the Institute for Res
'"/>

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
11-Apr-2007


Page: 1 2 3 4

Related biology news :

1. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
2. Does the desire to consume alcohol and tobacco come from our genetic makeup?
3. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
4. Penn researchers discover pathway that eliminates genetic defects in red blood cells
5. Identifying the mechanism behind a genetic susceptibility to type 2 diabetes
6. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis
7. Discoverer of Sly Syndrome finds way of delivering medicine to fight rare genetic disorder
8. Identified main genetic variants involved in response to HIV
9. Restless legs genetics on the move
10. UK scientists lift lid on genetics of coronary artery disease
11. Global community listens to TAU genetic researcher at EU Conference on Hearing Loss

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/4/2020)... PHOENIX (PRWEB) , ... July 03, 2020 , ... ... is proud to earn outstanding recognition and multiple awards for not only the ... the ABM portfolio, SoME® Skincare and Vivace® Microneedle RF. All the brands built ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... solutions for glioblastoma—the most common and aggressive adult brain cancer—announced today the appointments ... Senior Fellows are charged with supporting the organization’s initiatives and overall vision. , ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... gene-to-protein and monoclonal antibody development services, today announced that the company has ... services to the pharmaceutical, diagnostics, and research industries. The decision to pursue ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... August 03, 2020 , ... ... announced Jim Corrigan, President and CEO has been named one of the 100 ... of industry sectors, PharmaVoice 100 honorees are selected based on how they have ...
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products has ... different materials for use with CRM, neurostimulation, vascular, and related devices. , ... specific design requirements, performance, and cost criteria; especially where solid wire is limited. ...
(Date:7/22/2020)... TORONTO (PRWEB) , ... July 22, 2020 , ... Join ... and John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... is the regulating body in China for drugs and medical devices. Specifically, for medical ...
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, a ... laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume ... Bode-CARES provides a turnkey solution that includes a comprehensive collection and virus-management ...
Breaking Biology Technology:
Cached News: